Location of cytomegalovirus in white blood cell subsets
| Subject . | Peripheral blood . | FACS analysis (sample 2) . | |||||
|---|---|---|---|---|---|---|---|
| GE/mL . | GE/mL . | ||||||
| Sample 1 . | Sample 2 . | CD14 . | CD4 . | CD3 . | CD19 . | GRAN . | |
| 1 | 2 100 | — | POS | — | — | — | — |
| 2 | 25 200 | 4 800 | POS | — | — | — | — |
| 3 | — | 24 000 | POS | — | — | — | POS |
| 4 | — | — | — | — | — | — | — |
| 5 | — | — | — | — | — | — | — |
| 6 | 43 600 | — | POS | — | — | — | — |
| 7 | 17 400 | — | POS | — | — | — | — |
| 8 | 15 800 | — | POS | — | — | — | — |
| 9 | — | — | — | — | — | — | — |
| 10 | 2 600 | — | POS | — | — | — | — |
| 11 | — | — | — | — | — | — | — |
| 12 | — | — | POS | — | — | — | — |
| 13 | 300 | — | — | — | — | — | — |
| 14 | 3 100 | — | POS | — | — | — | — |
| 15 | 1 000 000 | 720 000 | POS | — | — | — | POS |
| 16 | — | — | — | — | — | — | — |
| 17 | — | — | POS | — | — | — | — |
| 18 | — | — | — | — | — | — | — |
| 19 | — | — | POS | — | — | — | — |
| 20 | 3 800 | — | POS | — | — | — | POS |
| Subject . | Peripheral blood . | FACS analysis (sample 2) . | |||||
|---|---|---|---|---|---|---|---|
| GE/mL . | GE/mL . | ||||||
| Sample 1 . | Sample 2 . | CD14 . | CD4 . | CD3 . | CD19 . | GRAN . | |
| 1 | 2 100 | — | POS | — | — | — | — |
| 2 | 25 200 | 4 800 | POS | — | — | — | — |
| 3 | — | 24 000 | POS | — | — | — | POS |
| 4 | — | — | — | — | — | — | — |
| 5 | — | — | — | — | — | — | — |
| 6 | 43 600 | — | POS | — | — | — | — |
| 7 | 17 400 | — | POS | — | — | — | — |
| 8 | 15 800 | — | POS | — | — | — | — |
| 9 | — | — | — | — | — | — | — |
| 10 | 2 600 | — | POS | — | — | — | — |
| 11 | — | — | — | — | — | — | — |
| 12 | — | — | POS | — | — | — | — |
| 13 | 300 | — | — | — | — | — | — |
| 14 | 3 100 | — | POS | — | — | — | — |
| 15 | 1 000 000 | 720 000 | POS | — | — | — | POS |
| 16 | — | — | — | — | — | — | — |
| 17 | — | — | POS | — | — | — | — |
| 18 | — | — | — | — | — | — | — |
| 19 | — | — | POS | — | — | — | — |
| 20 | 3 800 | — | POS | — | — | — | POS |
From the spring 1998 cohort, 10 DNAemia positive and 10 negative subjects were identified from the initial screening (sample 1) of peripheral blood samples (limit of detection 100 GE/mL). During a subsequent visit, a second sample (sample 2) was obtained. White blood cells (WBCs) were isolated and sorted by surface antigen phenotype. Isolated subpopulations were then assayed by QA-PCR. The CMV was detected in monocytes (CD14) in 13 of 20 samples, even for those samples that had a titer of less than or equal to 100 GE/mL. Cytomegalovirus (CMV) was detected in the granulocyte fraction for 3 subjects.
GE indicates genome equivalents; FACS, fluorescence-activated cell sorter; POS, positive; GRAN, granulocyte.